Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain

Madrid cohort of HIV-infected children, Miguel de Mulder, Gonzalo Yebra, Leticia Martín, Luís Prieto, María José Mellado, Pablo Rojo, María Ángeles Muñoz-Fernández, Santiago Jiménez de Ory, José Tomas Ramos, Africa Holguín

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

BACKGROUND: Drug resistance mutations affect antiretroviral therapy (ART) effectiveness in HIV-1-infected children, compromising long-term therapy. HIV-1 variants and drug resistance mutations were identified in HIV-infected children from Madrid, Spain.

METHODS: Patients from the Madrid cohort of HIV-infected children (1993-2009) with available pol sequences or infected samples stored at the Spanish HIV-1 BioBank were selected. Specimens were used to perform new pol sequences when not available. HIV-1 variants were characterized by phylogenetic analysis. Resistance mutations were identified according to the International AIDS Society-USA list (2009).

RESULTS: In 198 patients, pol sequences were recovered from routine resistance testing (n = 98) or newly performed using stored plasma, lymphocytes or DNA (n = 100). Patients were mostly Europeans (90%), with moderate to severe AIDS symptoms (65%), on ART (85%) when the specimen was sequenced and infected by subtype B (90%). Among the 19 HIV-1 non-B variants found, 58% were recombinants (8CRF02_AG, 1CRF08_BC, 1CRF12_BF and 1CRF13_cpx) and the rest were 'pure' non-B subtypes (1A2, 2C, 2D, 1F1, 1G and 1H). Transmitted drug resistance (TDR) mutations were detected in 13% of naive children; 4%, 7% and 10% for protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs), respectively. Global resistance prevalence was higher (66%) among ART-exposed children; 37% for PIs, 54% for NRTIs and 35% for NNRTIs.

CONCLUSIONS: HIV-1 non-B variants infected 10% of the cohort during 1993-2009. Resistant viruses were present in 26.5% and 66% of naive and pretreated children, respectively. Our data suggest that TDR prevalence in children could be higher than that reported in adults in Spain. The provided data will help to improve clinical management of HIV-infected children in Spain.

Original languageEnglish
Pages (from-to)2362-71
Number of pages10
JournalJournal of Antimicrobial Chemotherapy
Issue number10
Early online date2 Aug 2011
Publication statusPublished - Oct 2011

Keywords / Materials (for Non-textual outputs)

  • Acquired Immunodeficiency Syndrome
  • Adolescent
  • Anti-HIV Agents
  • Antiretroviral Therapy, Highly Active
  • Base Sequence
  • Child
  • Child, Preschool
  • Cohort Studies
  • Drug Resistance, Viral
  • Female
  • HIV Infections
  • HIV-1
  • Humans
  • Infant
  • Male
  • Molecular Sequence Data
  • Mutation
  • Phylogeny
  • Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Sequence Analysis, DNA
  • Spain
  • pol Gene Products, Human Immunodeficiency Virus
  • Journal Article
  • Research Support, Non-U.S. Gov't


Dive into the research topics of 'Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain'. Together they form a unique fingerprint.

Cite this